Scholars Central

Conference abstractPublished 29 Jun 2017

Contralateral prophylactic mastectomy with reconstruction increases health care utilization and cost

Authors: Judy C Boughey, Stephanie R Schilz, Lin Zhu, Elizabeth B Habermann, Valerie Lemaine

Mayo Clinic, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Rates of contralateral prophylactic mastectomy in women with unilateral breast cancer continue to rise, especially in women undergoing immediate breast reconstruction (IBR). Methods: We utilized administrative claims data from a large U.S. commercial insurance database (OptumLabs) to identify women age 18+ years who underwent IBR 1/2004-12/2013. We compared 2-year total costs of care and unadjusted utilization rates between unilateral mastectomy (UM) and bilateral mastectomy (BM) for implant-based and autologous reconstruction. Comparisons were tested using t-test and differences in cost were estimated with Wilcoxon rank sum test. Results: 11,728 women undergoing mastectomy with IBR were identified; 7,693 with implant reconstruction (2,090, 27% UM and 5,603, 73% BM) and 4,035 with autologous reconstruction (1,754, 43% UM and 2,281, 57% BM). Mean hospital length of stay at initial surgery and overall rate of office visits was similar between BM+IBR and UM+IBR, however rate of A&E visits was higher for BM+IBR (34.2 per 100 women vs. 30.2, p<0.0001). For implant reconstruction total 2-year cost of care was higher for BM+IBR than UM+IBR for commercial insurance ($106,469 vs. $96,689, p<0.001) however it was not significantly different for medicare advantage. For autologous reconstruction, total medicare advantage 2-year cost of care was higher for BM+IBR ($57,602 vs $37,713, p=0.027) with even greater differences seen in commercial insurance. Conclusion: BM+IBR (autologous or implant) was associated with increased A and E visits and higher total cost of care over 2-years compared to UM+IBR. Patients considering contralateral prophylactic mastectomy should be counseled on the additional risks and costs associated with BM+IBR.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Breast Cancer: Current Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBreast Cancer: Current Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Judy C Boughey”
  • BylineArticles whose byline prints “Stephanie R Schilz”
  • BylineArticles whose byline prints “Lin Zhu”
  • BylineArticles whose byline prints “Elizabeth B Habermann”
  • BylineArticles whose byline prints “Valerie Lemaine”